Abstract
Background : Attention Deficit Hyperactivity Disorder (ADHD) often persists into adulthood. Controlled trials in adults with ADHD show that stimulant treatment is effective. Method: Ninety-six patients referred to a clinic for adults with ADHD were systematically assessed. An open trial of pemoline was carried out on patients with ADHD. Results : Thirty patients met criteria for ADHD. They were more likely to be male, have dissocial and impulsive personality disorders and have abused psychoactive substances in the previous three months. Developmental milestones (walking and talking) were delayed in patients with ADHD. At 6 months, 10 of 25 patients remained on treatment and were 'minimally' or 'much improved' on the Clinical Global Impression Scale. Conclusions: Some adults with ADHD benefit from stimulant treatment. Children treated for ADHD should be followed up into adulthood as many will continue to benefit from treatment. Clinicians need knowledge in the diagnosis and treatment of ADHD in adults.